Quantcast

Cardiac Implant Medical Device Market worth US$ 27 Billion by 2017

July 8, 2014

LifeScienceIndustryResearch.com adds Latest Report on “Global Cardiac Bio Implant Devices (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent, Ventricular Assist Device) Market Forecast, Clinical Trials, M&A” to its store.

DALLAS, July 8, 2014 /PRNewswire-iReach/ — The cardiac implant medical device market is forecasted to grow in single digit percent per year during 2010-2017 and is likely to exceed US$ 27 Billion by 2017. Growth in this sector is anticipated to grow despite continuing product recalls and safety controversies, particularly in the Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers segment. Product innovation, together with demographic structure of the world population, will play a pivotal role in the future growth of the market. Additionally, developing healthcare sector and advanced infrastructure along with infusion of new professional skills and expertise in emerging economies continue to propel long-term growth opportunities for manufacturers operating in the market.

Photo – http://photos.prnewswire.com/prnh/20140707/124758

This report provides a comprehensive assessment of the fast-evolving, high-growth global cardiac implant market. This 284 page report with 258 Figures and 24 Tables studies the Global Cardiac Implant Device Market. This report contains 24 chapters and has been bifurcate into 10 segments.

    --  Worldwide Cardiac Implants Device Analysis (Chapter 2)
    --  Implantable Cardioverter Defibrillators (ICD) (Chapter 3 to 5)
    --  Implantable Cardiac Pacemakers (ICP) (Chapter 6 to 8)
    --  Heart Valve (Chapter 9 to 11)
    --  Coronary Stent (Chapter 12 to 15)
    --  Perpheral Stent (Chapter 16 to 17)
    --  Ventricular Assist Device (Chapter 18 to 20)
    --  Cardiac Implants Devices Clinical Trial Statement (Chapter 21)
    --  Merger & Acquisitions (Chapter 22)
    --  Growth Drivers & Challenges (Chapter 22 to 24)

Order a copy of this report at http://www.lifescienceindustryresearch.com/purchase?rname=14760 .

All the above segments have been further sub divided into

    --  Market & Forecast (2008 - 2017)
    --  Sales Unit & Forecast (By Volume) (2008 - 2017)
    --  Market Share & Forecast (2008 - 2017)
    --  Companies Market Share & Forecast(2008 - 2017)
    --  Companies Revenue & Forecast (2008 - 2017)
    --  Clinical Trial Statement
    --  Merger & Acquisition
    --  Growth Driver & Challenges

The Following 24 Chapters Contains

    --  ?First chapter is Executive Summary.
    --  ?Second chapter contains worldwide cardiac implants device market,
        market share & forecast (2010 - 2017).
    --  ?Third to Fifth chapter contains implantable cardioverter defibrillators
        (ICD) (market, sales unit/volume, market share, volume share, market
        forecast, volume forecast, geographic region & forecast, companies'
        revenue & forecast) (2008 - 2017).
    --  ?Sixth to Eighth chapter contains implantable cardiac pacemakers (ICP)
        (market, sales unit/volume, market share, volume share, market forecast,
        volume forecast, geographic region & forecast, companies' revenue &
        forecast) (2008 - 2017).
    --  ?Ninth to Eleventh chapter contains heart valve (market, sales
        unit/volume, market share, volume share, market forecast, volume
        forecast, geographic region & forecast, companies' revenue & forecast)
        (2009-2017).
    --  ?Twelfth to Fifteenth chapter contains coronary stent (market, sales
        unit/volume, market share, volume share, market forecast, volume
        forecast, geographic region & forecast, companies' revenue & forecast)
        (2008-2017).
    --  ?Sixteenth to Seventeenth chapter contains peripheral stent (market,
        sales unit/volume, market share, volume share, market forecast, volume
        forecast, geographic region & forecast, companies' revenue & forecast)
        (2010-2017).
    --  ?Eighteenth to nineteenth chapter contains ventricular assist device
        (market, sales unit/volume, market share, volume share, market forecast,
        volume forecast, geographic region & forecast, companies' revenue &
        forecast) (2010-2017).
    --  ?Twentieth to Twenty Three chapters contains clinical trial statement,
        merger & acquisition, growth driver & challenges.

Company Analysis (By Segment) – Revenue & Forecast

    --  Implantable Cardioverter Defibrillators (ICD): Boston Scientific, St
        Jude Medical, Medtronic & Others
    --  Implantable Cardiac Pacemakers (ICP): Medtronic, Boston Scientific, St
        Jude Medical, & Others
    --  Heart Valve: Edwards Lifesciences, Medtronic, St. Jude Medical, Sorin
        Group & Others
    --  Coronary Stent: Abbott Laboratories, Boston Scientific, Medtronic,
        Cordis Corporation (Johnson & Johnson), Others

Geographic Region (By Countries) – Market, Sales Unit (Volume) & Forecast

    --  Implantable Cardioverter Defibrillators (ICD): Worldwide, United States
        & Rest of the World (ROW)
    --  Implantable Cardiac Pacemakers (ICP): Worldwide, United States & Rest of
        the World (ROW)
    --  Heart Valve: Worldwide
    --  Coronary Stent (Drug Eluting Stent & Bare Metal Stent): Worldwide,
        United States, Japan, Europe & Rest of the World (ROW)
    --  Peripheral Stent: Worldwide
    --  Ventricular Assist Device: Worldwide, United States & Rest of World
        (ROW)

Clinical Trail Analysis – By Company

Edwards Lifesciences, St. Jude Medical, Boston Scientific, Medtronic, Sorin Group, Abbott Laboratories

Comprehensive Table of Contents and more for the report “Global Cardiac Bio Implant Devices (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent, Ventricular Assist Device) Market Forecast, Clinical Trials, M&A” is available at http://www.lifescienceindustryresearch.com/global-cardiac-bio-implant-devices-implantable-cardioverter-defibrillators-implantable-cardiac-pacemakers-heart-valve-coronary-stent-peripheral-stent-ventricular-assist-device-market-forecast.html .

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

Few Points from Table of Contents

List of Tables

Table 21 1: Clinical Trial – The Partner Trial: Placement of Aortic Transcatheter Valve Trial

Table 21 2: Clinical Trial – The Partner II Trial: Placement of Aortic Transcatheter Valve Trial

Table 21 3: Clinical Trial – Risk Stratification & Benefits with Cardiac Resynchronization Therapy (CRT)

Table 21 4: Clinical Trial – Comparison between FFR Guided Revascularization versus Conventional Strategy in Acute STEMI Patients with MVD

Table 21 5: Clinical Trial – FAME II – FFR Guided PCI plus Optimal Medical Treatment (OMT) verses OMT Alone in Patients with Stable Coronary Artery Disease

Table 21 6: Clinical Trial – Prevent: Promus BTK

Table 21 7: Clinical Trial – Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT) Post Approval Registry

Table 21 8: Clinical Trial – Supernova Clinical Stenting Trial

Table 21 9: Clinical Trial – Comparison of Biolimus-eluting Biodegradable Polymer, Everolimus-eluting and Sirolimus-eluting Coronary Stents (BESS)

About Us:

Life Science Industry Research is a database of selected syndicated market reports for global and China industries including but not limited to life sciences, biotechnology, diagnostics, healthcare as well as medical devices and pharmaceuticals. We provide 24/7 online and offline support to our customers. Call +1 888 391 5441 with your research requirements or email the details on sales@lifescienceindustryresearch.com Phone and we would be happy to help you find the business intelligence that you need.

Media Contact: Ritesh Tiwari, Life Science Industry Research, + 1 888 391 5441, sales@lifescienceindustryresearch.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE Life Science Industry Research


Source: PR Newswire



comments powered by Disqus